Results 261 to 270 of about 5,867,860 (378)

Defining the proteome of bone marrow plasma in multiple myeloma and monoclonal gammopathy of undetermined significance. [PDF]

open access: yesBlood Cancer J
Hsu JS   +12 more
europepmc   +1 more source

PB2101 FUNCTIONAL SIGNIFICANCE OF OVEREXPRESSION OF MITOTIC CHECKPOINT PROTEIN BUB1 IN MULTIPLE MYELOMA

open access: gold, 2019
Yuto Fujibayashi   +11 more
openalex   +1 more source

Classification of Platelet‐Activating Anti‐Platelet Factor 4 Disorders

open access: yesInternational Journal of Laboratory Hematology, EarlyView.
ABSTRACT Introduction The prototypic anti‐platelet factor 4 (PF4) disorder—heparin‐induced thrombocytopenia and thrombosis (HITT)—features immunoglobulin G (IgG) class antibodies that activate platelets, monocytes, and neutrophils in a mainly heparin‐dependent fashion via Fcγ receptor‐dependent cellular activation.
Theodore E. Warkentin
wiley   +1 more source

HERV-K Envelope Induce a Humoral Response in Non-Hodgkin Lymphoma Patients. [PDF]

open access: yesCurr Microbiol
Cossu I   +7 more
europepmc   +1 more source

Monitoring Minimal Residual Disease in Patients with Multiple Myeloma by Targeted Tracking Serum M-Protein Using Mass Spectrometry (EasyM) [PDF]

open access: hybrid
Huishou Fan   +20 more
openalex   +1 more source

The urinary albumin‐to‐creatinine ratio can direct personalized prevention and treatment for cardiovascular and chronic kidney disease

open access: yesJournal of Internal Medicine, EarlyView.
Abstract Increased urinary albumin excretion is a strong predictor for cardiovascular events in persons with and without decreased glomerular filtration rate and can be assessed with the urinary albumin‐to‐creatinine ratio (UACR), which is a selective, sensitive, and convenient method for patients.
Holly J. Kramer, George L. Bakris
wiley   +1 more source

Bortezomib blocks Bax degradation in malignant B cells during treatment with TRAIL [PDF]

open access: yes, 2008
Adrian C. Newland   +61 more
core   +1 more source

When Autoimmunity Meets Malignancy: A Rare Case of Concomitant Systemic Lupus and Multiple Myeloma. [PDF]

open access: yesClin Case Rep
Ratsimbazafy SJN   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy